The Analytical Biochemistry Shared Resource (ABSR) facility has been providing cost-effective and accurate chemical analyses for molecules relevant to cancer research to UHCC investigators since 1990. ABSR has also served as the base for consultation related to analyte quantitation and strategies in analytical chemistry in addition to providing services and expertise in advanced methods for the determination of biomarkers, metabolites, or any organic chemicals using a state-of-the-art analytical chemistry approach including high performance liquid chromatography (HPLC) with mass spectrometry (MS), photo-diode array (PDA), electrochemical (EC), fluorescence (F), and other highly sensitive detectors. ABSR has established routine clinical chemistry and single/multiplexed immunoassays including those utilizing Luminex technology for cost- effective analyses. A host of new assays has also been implemented in the current cycle due to the rising needs of CC members. The high quality of services is continually monitored by ABSR?s participation in internal and external quality assurance programs such as the round robin tests organized by the National Institute of Standards and Technology. ABSR provides state-of-the-art analytical chemistry services, which include developing methods for simultaneous analyses of multiple analytes across various analytical platforms (LCMS, HPLC, ELISA, clinical autoanalyzer). In addition, ABSR provides timely feedback on all project, providing the most cost-efficient strategies as possible, and stimulating inter-disciplinary collaborations within the CC and other institutions. No other laboratories in the State of Hawaii are available to provide this array of services particularly regarding the type, speed, cost, and combination of assays, many of which are custom designed by this core to fulfill the specific requirements of CC projects. The current use of the ABSR facility at full capacity is anticipated to continue for the foreseeable future. Newly funded projects requiring services of the resource will outnumber projects terminating in the coming years. Equipment obtained in the current cycle (high-resolution accurate-mass spectrometry system) has greatly enhanced the capabilities of this resource. In FY12-17 this facility has shown remarkable productivity by a total of 59 cancer related peer reviewed publications that involved services for UHCC investigators by ABSR (33 inter-programmatic, 24 intra-programmatic) and contributed significantly to scientific findings as detailed in the Research Strategy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA071789-20
Application #
9968041
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
20
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Hawaii
Department
Type
DUNS #
965088057
City
Honolulu
State
HI
Country
United States
Zip Code
96822
Naderi, Ali (2018) SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies. Mol Oncol 12:724-755
Franke, Adrian A; Li, Xingnan; Menden, Ariane et al. (2018) Oxytocin analysis from human serum, urine, and saliva by orbitrap liquid chromatography-mass spectrometry. Drug Test Anal :
Fanidi, Anouar; Muller, David C; Yuan, Jian-Min et al. (2018) Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3). J Natl Cancer Inst 110:
Rohrmann, Sabine; Shvetsov, Yurii B; Morimoto, Yukiko et al. (2018) Self-reported dietary flavonoid intake and serum markers of inflammation: the multiethnic cohort. Cancer Causes Control 29:601-607
Faouzi, Malika; Neupane, Ram P; Yang, Jian et al. (2018) Areca nut extracts mobilize calcium and release pro-inflammatory cytokines from various immune cells. Sci Rep 8:1075
Nishioka, Scott T; Sato, Miles M; Wong, Linda L et al. (2018) Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort. Hepatoma Res 4:
Marciel, Michael P; Rose, Aaron H; Martinez, Verena et al. (2018) Calpain-2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme. Cancer Med 7:175-183
Shi, Geng-Xian; Yang, Won Seok; Jin, Ling et al. (2018) RSK2 drives cell motility by serine phosphorylation of LARG and activation of Rho GTPases. Proc Natl Acad Sci U S A 115:E190-E199
Citronberg, Jessica S; Wilkens, Lynne R; Le Marchand, Loic et al. (2018) Plasma lipopolysaccharide-binding protein and colorectal cancer risk: a nested case-control study in the Multiethnic Cohort. Cancer Causes Control 29:115-123
Panizza, Chloe E; Shvetsov, Yurii B; Harmon, Brook E et al. (2018) Testing the Predictive Validity of the Healthy Eating Index-2015 in the Multiethnic Cohort: Is the Score Associated with a Reduced Risk of All-Cause and Cause-Specific Mortality? Nutrients 10:

Showing the most recent 10 out of 562 publications